title: Efficacy of mizoribine and prednisolone combination therapy in adult patients with IgA vasculitis.
abstract: Immunoglobulin (Ig)A vasculitis (IgAV), formerly known as Henoch-Schönlein purpura, is one of the most common vasculitis caused by an IgA-mediated immune complex. It occurs most frequently in childhood and less commonly in adulthood. As for the treatment of IgAV in adults, there are few studies dealing with the administration and efficacy of intravenous pulse steroid therapy or combination therapy using prednisolone (PSL) and immunosuppressive drugs. Mizoribine (MZB) is a newly developed immunosuppressive drug with few adverse effects; however, there are currently few studies using MZB in adult patients with IgAV. In this study, we evaluated the efficacy of MZB combined with a course of PSL in adult patients with IgAV. Five patients with adult onset IgAV were enrolled in the study. All patients received oral PSL (initial dose 30-50 mg/day), and MZB was administered orally at a single morning dose of 150 mg. We investigated the clinical manifestations and prognosis of these patients receiving the combination therapy of MZB and PSL retrospectively. All patients showed complete or partial remission of proteinuria and microscopic hematuria with the combination therapy of MZB and PSL. Furthermore, no significant adverse effects were observed. Although this study had an uncontrolled small group, our results indicate that the combination of MZB with PSL could be a possible new treatment for adult patients with IgAV.
authors.affiliation: Department of Nephrology, Kindai University Nara Hospital, Kindai University Faculty of Medicine, Nara, 630-0293, Japan. amima@med.kindai.ac.jp.
authors.forename: Akira
authors.initials: A
authors.lastname: Mima
mesh_terms: D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D004359:Drug Therapy, Combination; D006417:Hematuria / Q000652:urine; D006801:Humans; D011695:IgA Vasculitis / Q000188:drug therapy* / Q000652:urine; D007070:Immunoglobulin A / Q000652:urine; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D008297:Male; D011239:Prednisolone / Q000008:administration & dosage*; D011507:Proteinuria / Q000652:urine; D012189:Retrospective Studies; D012263:Ribonucleosides / Q000008:administration & dosage*
chemical_list: D007070:Immunoglobulin A; D007166:Immunosuppressive Agents; D012263:Ribonucleosides; C010052:mizoribine; D011239:Prednisolone
keywords: Clinical stage; Henoch–Schönlein purpura; IgA vasculitis; Mizoribine; Prednisolone